Skip to content

GW PHARMACEUTICALS PLC

Delisted

CIK 1351288fmd_1M80ZYVSG4RDD099TXWS64FB16Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Oct 01, 2015 to Mar 31, 2021, 19 periods

Latest annual · FY2020

Millions
Total revenues
527
Gross profit
490
Operating income
(52)
Net income
(58)
Free cash flow
(46)

Latest quarter · Q1 FY2021

Millions
Total revenues
152
Gross profit
141
Operating income
(21)
Net income
(20)
Free cash flow
(20)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2017 to FY2020
+293.9%

GW PHARMACEUTICALS PLC financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2020FY2019ChangeSource
Revenue$527.2 million10-K 2021-02-26 · proof
Gross profit$489.7 million10-K 2021-02-26 · proof
Operating income-$51.8 million-$118.4 million10-K 2021-02-26 · proof
Net income-$58.1 million-$9 million10-K 2021-02-26 · proof
Cash from operating activities-$27.4 million-$123.5 million10-K 2021-02-26 · proof
Free cash flow-$46 million-$163.9 million10-K 2021-02-26 · proof
Total assets$939.5 million$882.2 million+6.5%10-K 2021-02-26 · proof
Total liabilities$198.4 million$156.2 million+27%10-K 2021-02-26 · proof
Cash and cash equivalents$486.8 million$536.9 million-9.3%10-K 2021-02-26 · proof
What was GW PHARMACEUTICALS PLC's revenue in fiscal 2020?
GW PHARMACEUTICALS PLC reported revenue of $527.2 million for fiscal 2020 (the year ended Dec 31, 2020). Source: the 10-K filed with the SEC on Feb 26, 2021. SEC
What was GW PHARMACEUTICALS PLC's gross profit in fiscal 2020?
GW PHARMACEUTICALS PLC reported gross profit of $489.7 million for fiscal 2020 (the year ended Dec 31, 2020). Source: the 10-K filed with the SEC on Feb 26, 2021. SEC
What was GW PHARMACEUTICALS PLC's operating income in fiscal 2020?
GW PHARMACEUTICALS PLC reported operating income of -$51.8 million for fiscal 2020 (the year ended Dec 31, 2020), against -$118.4 million the year before. Source: the 10-K filed with the SEC on Feb 26, 2021. SEC
What was GW PHARMACEUTICALS PLC's net income in fiscal 2020?
GW PHARMACEUTICALS PLC reported net income of -$58.1 million for fiscal 2020 (the year ended Dec 31, 2020), against -$9 million the year before. Source: the 10-K filed with the SEC on Feb 26, 2021. SEC
What was GW PHARMACEUTICALS PLC's cash from operating activities in fiscal 2020?
GW PHARMACEUTICALS PLC reported cash from operating activities of -$27.4 million for fiscal 2020 (the year ended Dec 31, 2020), against -$123.5 million the year before. Source: the 10-K filed with the SEC on Feb 26, 2021. SEC
What was GW PHARMACEUTICALS PLC's free cash flow in fiscal 2020?
GW PHARMACEUTICALS PLC reported free cash flow of -$46 million for fiscal 2020 (the year ended Dec 31, 2020), against -$163.9 million the year before. Source: the 10-K filed with the SEC on Feb 26, 2021. SEC
What are GW PHARMACEUTICALS PLC's total assets?
As of Dec 31, 2020, GW PHARMACEUTICALS PLC reported total assets of $939.5 million, against $882.2 million a year earlier (+6.5%). Source: the 10-K filed with the SEC on Feb 26, 2021. SEC
What are GW PHARMACEUTICALS PLC's total liabilities?
As of Dec 31, 2020, GW PHARMACEUTICALS PLC reported total liabilities of $198.4 million, against $156.2 million a year earlier (+27%). Source: the 10-K filed with the SEC on Feb 26, 2021. SEC
What are GW PHARMACEUTICALS PLC's cash and cash equivalents?
As of Dec 31, 2020, GW PHARMACEUTICALS PLC reported cash and cash equivalents of $486.8 million, against $536.9 million a year earlier (-9.3%). Source: the 10-K filed with the SEC on Feb 26, 2021. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1351288&period_type=annual&limit=5"

Information only, not investment advice.